Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Iambic Therapeutics

Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 22, 2026

Sentiment
30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Iambic Therapeutics, a San Diego-based drug developer backed by Nvidia and the Qatar Investment Authority, filed for a US initial public offering on Monday, September 21, 2026, aiming to list on the Nasdaq under the…
Impact: The central entity of the event, filing for a US IPO on Nasdaq under symbol IAM and unveiling an AI drug discovery collaboration with AbbVie. A successful listing would give it fresh capital and public-market valuation.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Iambic Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.